What every dentist should know about the "z-sedatives"

Area of Science:

• Pharmacology
• Sleep Medicine
• Dental Practice

Background:

• Sleep disruption affects a significant portion of the American population.
• Prescription sleep medications are a common treatment for insomnia.
• Historically, barbiturates and benzodiazepines were primary treatments, but nonbenzodiazepines (z-sedatives) are now more prevalent.

Purpose of the Study:

• To inform dentists about the mechanism of action and potential drug interactions of commonly prescribed sleep medications.
• To highlight the increasing use of z-sedatives in dental practice.

Main Methods:

• Review of historical and current sleep medication classes.
• Discussion of the prevalence of insomnia and sleep disruption.
• Examination of the role of sleep medications in dental settings.

Main Results:

• Benzodiazepines like triazolam, diazepam, and oxazepam were once standard insomnia treatments.
• Nonbenzodiazepine z-sedatives, such as zolpidem (Ambien), zaleplon (Sonata), and eszopiclone (Lunesta), are now the most frequently prescribed.
• Zolpidem tartrate, a generic form of Ambien, has received FDA approval.
• Dentists commonly prescribe these medications for pre-appointment anxiety and as procedural sedatives.

Conclusions:

• Dentists must be aware of the pharmacological profiles of z-sedatives.
• Understanding potential drug interactions is crucial for patient safety in dental settings.
• The widespread use of sleep medications necessitates ongoing education for dental professionals.